It has the advantage of circumventing the neonatal lethality of Mmut-ko/ko null mutants (10,11) and displays a strong metabolic phenotype accompanied by many clinical features of methylmalonic aciduria including a pronounced failure to thrive, which are strengthened when challenged with a 51%-protein diet from day 12 of life (12). The gene discussed is KRT8; the disease is Failure to thrive.